The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.
Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Abstract
Interferon (IFN)-alpha is a cytokine of the innate immune response that is well known for inducing behavioral alterations and has been used to study effects of cytokines on the nervous system. Limited data, however, are available on the sites of action of IFN-alpha within the brain and their relationship with specific IFN-alpha-induced symptoms. Using a longitudinal design, whole-brain metabolic activity as assessed by fluorine-18-labeled fluorodeoxyglucose uptake and positron emission tomography was examined before and 4 weeks after IFN-alpha administration in patients with malignant melanoma. Changes in metabolic activity in relevant brain regions were then correlated with IFN-alpha-induced behavioral changes. IFN-alpha administration was associated with widespread bilateral increases in glucose metabolism in subcortical regions including the basal ganglia and cerebellum. Decreases in dorsal prefrontal cortex glucose metabolism were also observed. Prominent IFN-alpha-induced behavioral changes included lassitude, inability to feel, and fatigue. Correlational analyses revealed that self-reported fatigue (specifically as assessed by the 'energy' subscale of the Visual Analog Scale of Fatigue) was associated with increased glucose metabolism in the left nucleus accumbens and putamen. These data indicate that IFN-alpha as well as other cytokines of the innate immune response may target basal ganglia nuclei, thereby contributing to fatigue-related symptoms in medically ill patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IFNα administration was found to be associated with increased glucose metabolism in the basal ganglia and cerebellum, which are involved in motor activity and motivation”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Capuron et al., 2007
In the citing paper
“the observed NDI increase has been interpreted as representing the inflammatory process.”
From NODDI in clinical research (2020) · cites this paper as Capuron et al., 2007
In the citing paper
“In agreement with this, cancer patients treated with IFN-α display decreased glucose metabolism in the dorsal prefrontal cortex but increased glucose metabolism in the cerebellum and basal ganglia73.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [73]
In the citing paper
“IFN-α therapy led to reports of fatigue in a sample of patients with malignant melanoma that were positively correlated with increased glucose metabolism in the basal ganglia (the left putamen and left NAc) (Capuron et al., 2007).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Capuron et al., 2007
In the citing paper
“IFN-α therapy led to reports of fatigue in a sample of patients with malignant melanoma that were positively correlated with increased glucose metabolism in the basal ganglia (the left putamen and left NAc) (Capuron et al., 2007).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Capuron et al., 2007
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages
Cox, R. W. (1996) · Computers and Biomedical Research · doi:10.1006/cbmr.1996.0014 · Cited by 10,913
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Forman, S. D., Cohen, J. D., Fitzgerald, M., Eddy, W. F., Mintun, M. A., & Noll, D. C. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910330508 · Cited by 3,202
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Self-citationThe Mini-Mental State Examination
Folstein, M. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790060110016 · Cited by 1,936
Cited by
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Self-citationSlavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
“In another study using this same model, IFN- administration was found to be associated with increased glucose metabolism in the basal ganglia and cerebellum, which are involved in motor activity and motivation (Capuron et al., 2007).”
BackgroundImmune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
“…including the activation of the HPA axis and corticotropin-releasing hormone (CRH) and the alteration of the metabolism of key monoamines (e.g., serotonin, DA, norepinephrine) (Dantzer et al., 1999; Capuron and Miller, 2004; Raison et al., 2006; Capuron et al., 2007a; Miller et al., 2009).”
BackgroundSelf-citationInflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
“…comes from neuoroimaging studies in humans examining basal ganglia activity after administration of IFN-alpha or immune activating stimuli (e.g. LPS or typhoid vaccination) (Capuron et al., 2007, Brydon et al., 2008, Harrison et al., 2009b, Eisenberger et al., 2010, Capuron et al., 2012).”
BackgroundHaroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
“…have indicated altered blood flow and metabolic activity in basal ganglia nuclei during exposure to inflammatory stimuli (Juengling et al, 2000; Capuron et al, 2007; Brydon et al, 2008), and in studies in non-human primates, reduced CSF concentrations of the dopamine metabolite, homovanillic…”
BackgroundMethodSelf-citationMiller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892
Self-citationInflammation-associated depression: From serotonin to kynurenine
Dantzer, R., O’Connor, J. C., Lawson, M. A., & Kelley, K. W. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.012 · Cited by 726
“Patients with malignant melanoma treated with IFNα displayed decreased glucose metabolism in dorsal prefrontal cortex and increased glucose metabolism in the basal ganglia and cerebellum (Capuron et al 2007).”
BackgroundFelger, J. C., Li, Z., Haroon, E., Woolwine, B. J., Jung, M. Y., Hu, X., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.168 · Cited by 620
Self-citationNeuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
Miller, A. H., Ancoli-Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.7805 · Cited by 608
Self-citationIs depression an inflammatory disorder?
Raison, C. L., & Miller, A. H. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0232-0 · Cited by 524
Self-citationDepression in HIV Infected Patients: a Review
Nanni, M. G., Caruso, R., Mitchell, A. J., Meggiolaro, E., & Grassi, L. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-014-0530-4 · Cited by 511
Calder, P. C., Bosco, N., Bourdet-Sicard, R., Capuron, L., Delzenne, N., Doré, J., Franceschi, C., Lehtinen, M. J., Recker, T., Salvioli, S., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.001 · Cited by 488
“Neuroimageing findings in patients chronically treated with cytokines (primarily, interferon-α) have documented important changes in brain basal metabolism together with alterations in brain frontal activity, basal ganglia circuitry and dopamine function (Capuron et al., 2012, 2007, 2005).”
Self-citationInflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
“…et al, 2000 [18F]FDG, glucose metabolism HCV+ patients 12 weeks IFN-α PFC ↓ Juengling et al, 2000 [18F]FDG, glucose metabolism MM patients 4 weeks IFN-α VS, DS ↑ Capuron et al, 2007 [18F]FDG, glucose metabolism MM patients 4 weeks IFN-α PFC ↓ Capuron et al, 2007 [11C]raclopride, D2R binding…”
BackgroundMethodInfluentialImaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 427
Rheumatoid arthritis and depression: an inflammatory perspective
Nerurkar, L., Siebert, S., McInnes, I. B., & Cavanagh, J. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30255-4 · Cited by 413
Felger, J. C., & Miller, A. H. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.003 · Cited by 391
Self-citationBrydon, L., Harrison, N. A., Walker, C., Steptoe, A., & Critchley, H. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.007 · Cited by 381
Capuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2094 · Cited by 382
Self-citationBower, J. E., & Lamkin, D. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.011 · Cited by 372
“…nigrostriatal tract in pa tients undergoing proinflammatory immunotherapy and a correlation between this activity and fatigue in cancer patients (Capuron et al., 2007; Juengling et al., 2000) could be mediated by decreased function of D2-like receptors in that area of the brain, giving rise to…”
BackgroundSalamone, J. D., Yohn, S. E., López-Cruz, L., San Miguel, N., & Correa, M. (2016) · Brain · doi:10.1093/brain/aww050 · Cited by 350
Cytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339
Self-citationDepression and immunity: A role for T cells?
Miller, A. H. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.09.009 · Cited by 337
“…ganglia and the dorsal anterior cingulate cortex (dACC), brain regions that subserve behaviors related to motor activity and motivation (basal ganglia) as well as anxiety, arousal and alarm (dACC) (Brydon et al., 2008; Capuron et al., 2005, 2007; Harrison et al., 2009b; Juengling et al., 2000).”
BackgroundSelf-citationNeuroplastic changes in depression: A role for the immune system
Eyre, H., & Baune, B. T. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.019 · Cited by 319
“Patients treated with IFN therapy show a sharp rise in depressive symptoms associated with increased metabolism in the dorsal ACC, increased TNF-a, as well as hypermetabolism and impaired activation of basal ganglia circuits (Capuron et al., 2005, 2007; Raison et al., 2010a).”
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
Inflammation, Glutamate, and Glia in Depression:A Literature Review
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289
Kamiya, K., Hori, M., & Aoki, S. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108908 · Cited by 321
Miller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261
“Studies by our group and others using positron emission tomography also have demonstrated that IFN-alpha increases resting-state glucose metabolism in basal ganglia nuclei including the putamen and nucleus accumbens (Capuron et al., 2007; Juengling et al., 2000).”
InfluentialSelf-citationShelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 261
Self-citationThe evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)
Raison, C. L., & Miller, A. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.2 · Cited by 253
Self-citationInflammation and the dimensions of depression: A review
Majd, M., Saunders, E. F. H., & Engeland, C. G. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100800 · Cited by 217
The role of cytokines in the pathophysiology of suicidal behavior
Ganança, L., Oquendo, M. A., Tyrka, A. R., Cisneros-Trujillo, S., Mann, J. J., & Sublette, M. E. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.008 · Cited by 217
“…was seen on fMRI during a visuospatial attention task in the inferior frontal gyrus and dorsal anterior cingulate (Capuron et al., 2005); and extensive bilateral rCMRglu increases were seen on FDG-PET in subcortical regions including basal ganglia and cerebellum (Capuron et al., 2007) studies.”
BackgroundInflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology
Goldsmith, D. R., Bekhbat, M., Mehta, N. D., & Felger, J. C. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.003 · Cited by 214
Felger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.115 · Cited by 214
“Of note, IFN-a-induced changes in basal ganglia glucose metabolism were correlated with fatigue (Capuron et al, 2007).”
BackgroundSelf-citationBower, J. E. (2019) · Cancer · doi:10.1002/cncr.31790 · Cited by 205
Hannestad, J., DellaGioia, N., Gallezot, J.-D., Lim, K., Nabulsi, N., Esterlis, I., Pittman, B., Lee, J.-Y., O’Connor, K. C., Pelletier, D., et al. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.06.010 · Cited by 204
“…body of literature shows that inflammatory stimuli can produce depressive-like symptoms in individuals without depression (Wright et al., 2005; Capuron et al., 2007, 2009; Eisenberger et al., 2010a,b; Hannestad et al., 2011b; Dellagioia et al., 2013) and modulate neuronal activity in regions…”
BackgroundKrogh, J., Benros, M. E., Jørgensen, M. B., Vesterager, L., Elfving, B., & Nordentoft, M. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.08.014 · Cited by 185
Inflammatory cytokine-associated depression
Lotrich, F. E. (2015) · Brain Research · doi:10.1016/j.brainres.2014.06.032 · Cited by 183
Karshikoff, B., Sundelin, T., & Lasselin, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00021 · Cited by 178
Felger, J. C., Li, L., Marvar, P. J., Woolwine, B. J., Harrison, D. G., Raison, C. L., & Miller, A. H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.010 · Cited by 176
“Positron emission tomography (PET) imaging in IFN-alpha-treated patients revealed increased basal ganglia glucose metabolism (consistent with Parkinson’s disease) that correlated with symptoms of fatigue (Capuron et al. 2007).”
Self-citationDooley, L. N., Kuhlman, K. R., Robles, T. F., Eisenberger, N. I., Craske, M. G., & Bower, J. E. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.006 · Cited by 176
A critical review of human endotoxin administration as an experimental paradigm of depression.
DellaGioia, N., & Hannestad, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.014 · Cited by 175
The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder
Woelfer, M., Kasties, V., Kahlfuss, S., & Walter, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.034 · Cited by 171
Kraynak, T. E., Marsland, A. L., Wager, T. D., & Gianaros, P. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.013 · Cited by 165
Capuron, L., Fornwalt, F. B., Knight, B. T., Harvey, P. D., Ninan, P. T., & Miller, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.017 · Cited by 164
“…basal ganglia in regulating motor activity, these data are compatible with altered glucose metabolism in basal ganglia nuclei (putamen, globus pallidus and nucleus accumbens) of IFN-alpha-treated subjects as measured by positron emission tomography (Capuron et al., 2007; Juengling et al., 2000).”
Self-citationMorris, G., Berk, M., Galecki, P., Walder, K., & Maes, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9090-9 · Cited by 161
“tigue [275].”
Neuropsychiatric Comorbidity in Obesity: Role of Inflammatory Processes
Castanon, N., Lasselin, J., & Capuron, L. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00074 · Cited by 161
Self-citationHaroon, E., & Miller, A. H. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_40 · Cited by 153
Self-citationTherapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Self-citationPrimary Sjogren's syndrome: too dry and too tired
Ng, W., & Bowman, S. (2010) · Rheumatology · doi:10.1093/rheumatology/keq009 · Cited by 175
Diet, gut microbiota and cognition
Proctor, C., Thiennimitr, P., Chattipakorn, N., & Chattipakorn, S. C. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-016-9917-8 · Cited by 144
“Dysregulation of the basal ganglia and dopamine function can lead to depression, fatigue, anxiety and psychomotor symptoms (i.e. abnormal eating behaviour) (Capuron et al. 2007; Capuron et al. 2012; Haroon et al. 2012; Liu and Hong 2003).”
BackgroundInflammation in depression: is adiposity a cause?
Shelton, R. C., & Miller, A. H. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/rshelton · Cited by 161
Self-citationGoldsmith, D. R., Haroon, E., Woolwine, B. J., Jung, M. Y., Wommack, E. C., Harvey, P. D., Treadway, M. T., Felger, J. C., & Miller, A. H. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.025 · Cited by 157
“…metabolism using 18F-fluorodeoxyglucose in IFN-alpha-treated patients showed increased glucose metabolism in basal ganglia regions believed to be secondary to impaired dopamine-mediated inhibition of oscillatory burst activity in basal ganglia nuclei (Capuron et al., 2007; Juengling et al., 2000).”
MethodSelf-citationThe interface of depression and cardiovascular disease: therapeutic implications
Seligman, F., & Nemeroff, C. B. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12738 · Cited by 165
Self-citationCan’t or Won’t? Immunometabolic Constraints on Dopaminergic Drive
Treadway, M. T., Cooper, J. A., & Miller, A. H. (2019) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2019.03.003 · Cited by 153
Self-citationHarrison, N. A., Cooper, E., Dowell, N. G., Keramida, G., Voon, V., Critchley, H. D., & Cercignani, M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.023 · Cited by 129
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Lucido, M. J., Bekhbat, M., Goldsmith, D. R., Treadway, M. T., Haroon, E., Felger, J. C., & Miller, A. H. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000043 · Cited by 137
“Increased metabolism in the left putamen and left nucleus accumbens in turn was associated with anergia and fatigue (Capuron et al., 2007).”
BackgroundSelf-citationMajer, M., Welberg, L. A. M., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.009 · Cited by 124
“…alterations (increases) in glucose metabolism in basal ganglia nuclei including the putamen, globus pallidus, and nucleus accumbens have been demonstrated in IFNalpha-treated subjects in two brain imaging studies using positron emission tomography (Juengling et al., 2000; Capuron et al., 2007).”
BackgroundMethodInfluentialSelf-citationMott, A. M., Nunes, E. J., Collins, L. E., Port, R. G., Sink, K. S., Hockemeyer, J., Müller, C. E., & Salamone, J. D. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1441-z · Cited by 125
“Conversely, lack of behavioral activation can be maladaptive; in humans, symptoms such as psychomotor slowing, anergia, and fatigue are fundamental aspects of depression, as well as other psychiatric and neurological disorders (Demyttenaere et al. 2005; Salamone et al. 2006, 2007; YurgelunTodd et al. 2007; Capuron et…”
BackgroundHoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 129
Cattaneo, A., Ferrari, C., Turner, L., Mariani, N., Enache, D., Hastings, C. N. M., Kose, M., Lombardo, G., McLaughlin, A. P., Nettis, M. A., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00874-7 · Cited by 128
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
Structural brain changes in patients with post-COVID fatigue: a prospective observational study
Heine, J., Schwichtenberg, K., Hartung, T. J., Rekers, S., Chien, C., Boesl, F., Rust, R., Hohenfeld, C., Bungenberg, J., Costa, A. S., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101874 · Cited by 128
Glucose Metabolism in the Insula and Cingulate Is Affected by Systemic Inflammation in Humans
Hannestad, J., Subramanyam, K., DellaGioia, N., Planeta-Wilson, B., Weinzimmer, D., Pittman, B., & Carson, R. E. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.097014 · Cited by 113
Azzinnari, D., Sigrist, H., Staehli, S., Palme, R., Hildebrandt, T., Leparc, G., Hengerer, B., Seifritz, E., & Pryce, C. R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.039 · Cited by 119
“…under study here (Amat et al., 2005; Maren et al., 2013; Moscarello and LeDoux, 2013) as well as the corresponding depression psychopathologies (Capuron et al., 2007; Disner et al., 2011; Mayberg, 2003; Price and Drevets, 2010; Savitz et al., 2013; Sibille et al., 2009; Strigo et al., 2008).”
Lasselin, J., Lekander, M., Axelsson, J., & Karshikoff, B. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.06.005 · Cited by 106
“The fact that striatal structures are sensitive to inflammation (Harrison et al., 2015c; Capuron et al., 2007, 2012; Dowell et al., 2015) and show a decreased response to positive reward during inflammation (Harrison et al., 2015c; Capuron et al., 2012) has been interpreted as being a part of the…”
Acute basal ganglia infarcts in poststroke fatigue: an MRI study
Tang, W. K., Chen, Y. K., Mok, V., Chu, C. W., Ungvari, G. S., Ahuja, A. T., & Wong, K. S. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5284-2 · Cited by 118
“BG hypermetabolism was also associated with fatigue during interferon therapy [7].”
BackgroundSalamone, J. D., Farrar, A. M., Font, L., Patel, V. B., Schlar, D. E., Nunes, E. J., Collins, L. E., & Sager, T. N. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.02.021 · Cited by 120
Interleukin-1 as a mediator of fatigue in disease: a narrative review
Roerink, M. E., van der Schaaf, M. E., Dinarello, C. A., Knoop, H., & van der Meer, J. W. M. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0796-7 · Cited by 112
Salamone, J. D., Correa, M., Ferrigno, S. M., Yang, J.-H., Rotolo, R. A., & Presby, R. E. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015107 · Cited by 119
“…and other disorders, and there has been a particular focus on the association between cytokines and motivational symptoms such as anergia and fatigue (Capuron et al., 2007, 2009; Dantzer et al., 2008, 2012, 2014; Dantzer, 2009; Miller, 2009; Cattaneo et al., 2013; Felger and Treadway, 2016).”
BackgroundFatigue in immune thrombocytopenia
Hill, Q. A., & Newland, A. C. (2015) · British Journal of Haematology · doi:10.1111/bjh.13385 · Cited by 102
“…of fatigue, promising non-invasive imaging techniques include proton magnetic resonance spectroscopic imaging to assess in-vivo brain metabolites (Gabbay et al, 2010) and positron emission tomography (Capuron et al, 2007), however animal models may also be useful in understanding CNS pathways.”
BackgroundVancassel, S., Capuron, L., & Castanon, N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00499 · Cited by 109
“Clinical studies also reveal some functional alterations of the dopaminergic reward system, in association with impairment in motivation and motor slowing (Capuron et al., 2007; Eisenberger et al., 2010; Capuron et al., 2012).”
BackgroundSelf-citationActivation of the kynurenine pathway is associated with striatal volume in major depressive disorder
Savitz, J. B., Dantzer, R., Meier, T. B., Wurfel, B. E., Victor, T. A., McIntosh, S. A., Ford, B. N., Morris, H. M., Bodurka, J., Teague, T. K., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.609 · Cited by 99
“Regarding the first finding, IDO activity is increased in the context of inflammation and thus the inverse relationship between Kyn/TRP and striatal volume is potentially consistent with the abnormal response to rewarding stimuli observed in patients treated with pro-inflammatory medications (Capuron et al., 2007; Har…”
ResultGuerra, F. B. D., Fonseca, J. L. I., Figueiredo, V. M. F., Ziff, E. B., & Konkiewitz, E. C. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-013-0177-7 · Cited by 102
“Moreover, neuroimaging studies provided data relating altered patterns of basal ganglia activation to symptoms of fatigue, psychomotor retardation, and depression in the context of cytokine elevation (Capuron et al. 2007; Brydon et al. 2008).”
BackgroundRege, S., & Hodgkinson, S. J. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413499077 · Cited by 99
“IFN-α administration is associated with widespread bilateral increases in glucose metabolism in subcortical regions including the basal ganglia (Capuron et al., 2007) and anterior cingulated, which are associated with fatigue and cognitive effects respectively (Capuron et al., 2005).”
BackgroundNunes, E. J., Randall, P. A., Santerre, J. L., Given, A. M., Sager, T. N., Correa, M., & Salamone, J. D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.068 · Cited by 98
Role of Inflammation in Depression and Treatment Implications
Felger, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_166 · Cited by 103
Xiao, C., Beitler, J. J., Higgins, K. A., Conneely, K. N., Dwivedi, B., Felger, J. C., Wommack, E. C., Shin, D. M., Saba, N. F., Ong, L. Y., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.10.016 · Cited by 97
“Moreover, malignant melanoma patients treated with the inflammatory cytokine, interferon-alpha, were found to exhibit alterations in basal ganglia glucose metabolism as well as dopamine function, which were related to fatigue (Capuron et al., 2007).”
BackgroundSelf-citationInfluences of dopaminergic system dysfunction on late-life depression
Taylor, W. D., Zald, D. H., Felger, J. C., Christman, S., Claassen, D. O., Horga, G., Miller, J. M., Gifford, K., Rogers, B., Szymkowicz, S. M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01265-0 · Cited by 89
Role of Inflammation in Depression: Implications for Phenomenology, Pathophysiology and Treatment
Raison, C. L., & Miller, A. H. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343966 · Cited by 88
Self-citationBorsini, A., Benedetto, M. G. D., Giacobbe, J., & Pariante, C. M. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa055 · Cited by 89
Role of Inflammation in the Development of Neuropsychiatric Symptom Domains: Evidence and Mechanisms
Capuron, L., & Castanon, N. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_14 · Cited by 98
Self-citationSmith, A. K., Simon, J. S., Gustafson, E. L., Noviello, S., Cubells, J. F., Epstein, M. P., Devlin, D. J., Qiu, P., Albrecht, J. K., Brass, C. A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.67 · Cited by 84
Self-citationAiming for a Better Understanding and Management of Cancer-Related Fatigue
Neefjes, E. C. W., van der Vorst, M. J. D. L., Blauwhoff-Buskermolen, S., & Verheul, H. M. W. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0076 · Cited by 97
Fiore, N. T., & Austin, P. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.04.012 · Cited by 87
“…cytokines tumor necrosis factor (TNF) and interleukin-6 (IL-6) in depressed individuals (Dowlati et al., 2010; Liu et al., 2012), and interferon-α (IFNα) immunotherapy is known to cause widespread neuropsychiatric symptoms (Capuron et al., 2002; Capuron et al., 2007; Pavol et al., 1995).”
Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes
Lasselin, J., Layé, S., Dexpert, S., Aubert, A., Gonzalez, C., Gin, H., & Capuron, L. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.03.003 · Cited by 77
“Moreover, studies conducted in our group have shown that inflammation plays a major role in the development of fatigue symptoms in medically ill patients treated with cytokines, notably interferon-a (Capuron et al., 2002, 2007).”
BackgroundSelf-citationWorden, L. T., Shahriari, M., Farrar, A. M., Sink, K. S., Hockemeyer, J., Müller, C. E., & Salamone, J. D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1396-0 · Cited by 86
“M. Shahriari University of Connecticut Health Center, Farmington, CT, USA Stahl 2002; Demyttenaere et al. 2005; Salamone et al. 2006, 2007; Yurgelun-Todd et al. 2007; Capuron et al. 2007; Majer et al. 2008).”
BackgroundNucleus accumbens cytoarchitecture predicts weight gain in children
Rapuano, K. M., Laurent, J. S., Hagler, D. J., Hatton, S. N., Thompson, W. K., Jernigan, T. L., Dale, A. M., Casey, B. J., & Watts, R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007918117 · Cited by 79
Advancing an Inflammatory Subtype of Major Depression
Miller, A. H. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20250289 · Cited by 99
Self-citationAcute Changes in Striatal Microstructure Predict the Development of Interferon-Alpha Induced Fatigue
Dowell, N. G., Cooper, E. A., Tibble, J., Voon, V., Critchley, H. D., Cercignani, M., & Harrison, N. A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.015 · Cited by 74
Brain structures implicated in inflammation-associated depression
Harrison, N. A. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_30 · Cited by 74
Dipasquale, O., Cooper, E. A., Tibble, J. A., Voon, V., Baglio, F., Baselli, G., Cercignani, M., & Harrison, N. A. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.011 · Cited by 78
“This finding is noteworthy as it supports earlier studies showing bilateral (though left predominant) increases in striatal 18fluoro-deoxy-glucose (Capuron et al., 2007) and 18fluorodopa uptake (Capuron et al., 2012) as well as leftsided increases in striatal glutamate/creatine ratio (Haroon et…”
ResultIs there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
Young, J. J., Silber, T., Bruno, D., Galatzer‐Levy, I. R., Pomara, N., & Marmar, C. R. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00072 · Cited by 86
Inflammation, reward circuitry and symptoms of anhedonia and PTSD in trauma-exposed women
Mehta, N. D., Stevens, J. S., Li, Z., Gillespie, C. F., Fani, N., Michopoulos, V., & Felger, J. C. (2020) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsz100 · Cited by 74
“…(R)VS and vmPFC was assessed separately, consistent with previous studies using similar methods and because inflammation may have greater effects on left striatum (Capuron et al., 2007; Di Martino et al., 2008; Kelly et al., 2009; Eisenberger et al., 2010; Haroon et al., 2014; Felger et al., 2016).”
MethodResultRus, G. Z., dos Santos, M. A. B., Abelaira, H. M., Ribeiro, K. F., Petronilho, F. C., Vuolo, F. S., Colpo, G. D., Pfaffenseller, B., Kapczinski, F. P., Dal‐Pizzol, F., et al. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.044 · Cited by 72
Han, T., Felger, J. C., Lee, A., Mister, D., Miller, A. H., & Torres, M. A. (2015) · Psycho-Oncology · doi:10.1002/pon.3831 · Cited by 82
Self-citationRaison, C. L., & Miller, A. H. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.194 · Cited by 72
“…and behavioral effects of chronic immune activation secondary to treatment with the cytokine IFN-α for either cancer or hepatitis C virus infection (Capuron et al , 2002, 2003a, 2003b, 2005, 2007, 2009; Wichers and Maes, 2004; Wichers et al , 2005b, 2006, 2007; Majer et al , 2008; Harrison et al…”
Self-citationInflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications
Bekhbat, M., Treadway, M. T., & Felger, J. C. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_294 · Cited by 73
The possible role of the kynurenine pathway in anhedonia in adolescents
Gabbay, V., Ely, B. A., Babb, J. S., & Liebes, L. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0685-7 · Cited by 73
“…and human studies have demonstrated that peripheral immunotherapy frequently induces depressive symptoms, particularly anhedonia, as well as leads to concurrent changes in the neural reward circuitry (Eisenberger et al. 2010; Miller 2009; Shuto et al. 1997; Capuron et al. 2007; Majer et al. 2008).”
BackgroundDavies, K. A., Cooper, E., Voon, V., Tibble, J. A., Cercignani, M., & Harrison, N. A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0790-9 · Cited by 76
Metadata
- Authors
- Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H.
- Affiliations
- Emory University (US)
- Corresponding author
- Miller, Andrew H
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2007-02-28
- Volume
- 32
- Issue
- 11
- Pages
- 2384-2392
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2072184805
- Cited by
- 229
- References
- 70
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 9 · 2020: 15 · 2019: 10 · 2018: 17 · 2017: 12 · 2016: 18 · 2015: 17 · 2014: 8 · 2013: 14 · 2012: 22
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
- Funders
- Abbott Laboratories
- American Foundation for Suicide Prevention
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- American Psychiatric Institute for Research and Education
- Emory University
- National Alliance for Research on Schizophrenia and Depression
- ACADIA Pharmaceuticals
- Neurocrine Biosciences
- Centers for Disease Control and Prevention
- Pfizer Pharmaceuticals
- National Institute of Mental Health (MH 067990, R01MH067990, MH069124, K05MH069124)
- National Institute on Drug Abuse (K08DA000367, DA-00367)
- National Institute of Biomedical Imaging and Bioengineering (EB002635, R01EB002635)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- interferon-alpha, basal ganglia, fatigue, glucose metabolism, nucleus accumbens, putamen, cerebellum, prefrontal cortex, melanoma, lassitude, immune-related adverse events
- MeSH terms
- Adult, Basal Ganglia, Behavioral Symptoms, Brain Mapping, Female, Humans, Immunologic Factors, Longitudinal Studies, Male, Middle Aged, Fatigue Syndrome, Chronic, Interferon-alpha, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.